Review IDs Certain Higher Mortality Risks for Patients With Fibromyalgia
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 14, 2023 -- Patients with fibromyalgia have an increased risk for mortality, particularly from infections and suicide; however, they appear to have a lower risk for death due to cancer, according to a review published online July 10 in RMD Open.
Yulia Treister-Goltzman, M.D., M.P.H., and Roni Peleg, M.D., from Ben-Gurion University of the Negev and Clalit Health Services, both in Israel, conducted a systematic review and meta-analysis to examine the link between fibromyalgia and mortality. Eight papers that assessed associations between fibromyalgia and mortality and provided an effect measure quantifying the relationship were included in the systematic review. A total of 188,751 patients were included in the fibromyalgia group.
The researchers found that the hazard ratio for all-cause mortality was increased (hazard ratio, 1.27; 95 percent confidence interval [CI], 1.04 to 1.51), but not for the subgroup diagnosed by the 1990 criteria. A borderline increased standardized mortality ratio (SMR) was seen for accidents (SMR, 1.95; 95 percent CI, 0.97 to 3.92), while the risks for mortality from infections and suicide were increased significantly (SMRs [95 percent CIs], 1.66 [1.15 to 2.38] and 3.37 [1.52 to 7.50], respectively). For cancer, the mortality rate was reduced (SMR, 0.82; 95 percent CI, 0.69 to 0.97). Significant heterogeneity was seen in the studies.
"Our review provides further proof that fibromyalgia patients should be taken seriously, with particular focus on screening for suicidal ideation, prevention of accidents, and prevention and treatment of infections," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.